Armata Pharmaceuticals (ARMP) EBITDA Margin (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported EBITDA Margin of -13838.71% for Q2 2020.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2020, Armata Pharmaceuticals' EBITDA Margin came in at -16506.84%; for FY2017, it was -13723.48%, down 4873.86 percentage points from FY2016.
- EBITDA Margin has a four-year change of +1425.90 percentage points (FY2013 to FY2017).
- By year, EBITDA Margin came in at -8849.62% in FY2016 (-6766.04 pp), -2083.58% in FY2015 (+1327.67 pp), -3411.25% in FY2014 (+11738.14 pp) and -15149.38% in FY2013.
- The Q2 2020 figure ranks as the highest quarterly EBITDA Margin since Q4 2017.
- The high point for year-over-year EBITDA Margin in five years was Q4 2017 (a gain of 42123.18 percentage points); the low point was Q4 2016 (a drop of 51241.62 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Armata Pharmaceuticals | 137.07 Mn | 84.78 Mn | - | -390.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -390.92% |
| Mar 31, 2026 | -1,050.06% |
| Dec 31, 2025 | -1,234.29% |
| Sep 30, 2025 | -639.00% |
| Jun 30, 2025 | -298.66% |
| Mar 31, 2025 | -1,591.45% |
| Dec 31, 2024 | -822.59% |
| Sep 30, 2024 | -317.63% |
| Mar 31, 2024 | -1,025.98% |
| Jun 30, 2020 | -13,838.71% |
| Dec 31, 2017 | -11,345.00% |
| Sep 30, 2017 | -1,718.42% |
| Jun 30, 2017 | -34,264.29% |
| Mar 31, 2017 | -11,262.07% |
| Dec 31, 2016 | -53,468.18% |
| Sep 30, 2016 | -11,420.69% |
| Jun 30, 2016 | -3,395.15% |
| Mar 31, 2016 | -4,185.85% |
| Dec 31, 2015 | -2,226.56% |
| Sep 30, 2015 | -1,622.38% |
API Access
Armata Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();